Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

Leukemia is known as a progressive malignant disease, which destroys the blood‐forming
organs and results in adverse effects on the proliferation and development of leukocytes and …

Early-stage detection of leukemia is a critical determinant for successful treatment of the
disease and can increase the survival rate of leukemia patients. The factors limiting the …

The emergence of multidrug resistance (MDR) in malignant tumors is the primary reason for
invalid chemotherapy. Antitumor drugs are often adversely affected by the MDR of tumor …

Simple Summary Dysregulated microRNA (miRNA) expression has been described in the
initiation and progression of a wide spectrum of hematologic malignancies. Moreover …

Cancer is a multifaceted disease that involves several molecular mechanisms including
changes in gene expression. Two important processes altered in cancer that lead to …

Abstract Background Recently, lncRNA-Testis developmental related gene 1 (TDRG1) was
proved to be a key modulator in reproductive organ-related cancers. The biological role of …

Background Cutaneous squamous cell carcinoma (CSCC) is a common type of skin
malignancy. MicroRNA-221 (miRNA-221) is a critical non-coding RNA in tumor initiation and …

Although tremendous progress has been made in treating childhood cancer, it is still one of
the leading causes of death in children worldwide. Because cancer symptoms overlap with …

MicroRNAs (miRNAs) are non-coding small RNA molecules that regulate gene expression
at the post-transcriptional/translational level. They act a considerable role not only in the …